The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
Page/Page column 137; 222
(2021/10/15)
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists
The synthesis and biological testing of novel classes of potent melanin-concentrating hormone (MCH-R1) antagonists based on pyrazolopiperazinone and pyrrolopiperazinone scaffolds are described.
Meyers, Kenneth M.,Mendez-Andino, Jose,Colson, Anny-Odile,Hu, X. Eric,Wos, John A.,Mitchell, Maria C.,Hodge, Karen,Howard, Jeremy,Paris, Jennifer L.,Dowty, Martin E.,Obringer, Cindy M.,Reizes, Ofer
p. 657 - 661
(2007/10/03)
More Articles about upstream products of 929017-48-1